FDA Inspection 1210115 — Baylor University Medical Center Transfusion Services

Baylor University Medical Center Transfusion Services — FEI 1629161

The FDA completed an inspection of Baylor University Medical Center Transfusion Services on June 13, 2023 in Dallas, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 13, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Dallas, TX (United States)